NZ603010A - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis - Google Patents

Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Info

Publication number
NZ603010A
NZ603010A NZ603010A NZ60301011A NZ603010A NZ 603010 A NZ603010 A NZ 603010A NZ 603010 A NZ603010 A NZ 603010A NZ 60301011 A NZ60301011 A NZ 60301011A NZ 603010 A NZ603010 A NZ 603010A
Authority
NZ
New Zealand
Prior art keywords
therapy
optimization
renal failure
hemodialysis
prediction
Prior art date
Application number
NZ603010A
Other languages
English (en)
Inventor
Alp Akonur
John Kenneth Leypoldt
Ying-Cheng Lo
Baris Ugur Agar
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of NZ603010A publication Critical patent/NZ603010A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)
NZ603010A 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis NZ603010A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
PCT/US2011/032735 WO2011130668A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (1)

Publication Number Publication Date
NZ603010A true NZ603010A (en) 2014-05-30

Family

ID=44041518

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ603010A NZ603010A (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
NZ602996A NZ602996A (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ602996A NZ602996A (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Country Status (10)

Country Link
EP (3) EP2558966B1 (enExample)
JP (8) JP6018567B2 (enExample)
AU (2) AU2011239489B2 (enExample)
BR (1) BR112012026361A2 (enExample)
CA (2) CA2796505C (enExample)
CO (3) CO6660434A2 (enExample)
ES (2) ES2802609T3 (enExample)
MX (5) MX389975B (enExample)
NZ (2) NZ603010A (enExample)
WO (2) WO2011130668A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8868350B2 (en) 2010-04-16 2014-10-21 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
CA2919223A1 (en) * 2013-08-16 2015-02-26 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3539586B1 (en) 2014-10-10 2022-08-24 NxStage Medical Inc. Flow balancing methods
US10898635B2 (en) 2016-07-18 2021-01-26 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
WO2020185829A1 (en) 2019-03-11 2020-09-17 Fresenius Medical Care Holdings, Inc. Techniques for determining acid-base homeostasis
WO2020237228A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统
JP2024113409A (ja) 2023-02-09 2024-08-22 フィジオロガス・テクノロジーズ株式会社 診療支援システム

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
WO1994009351A1 (en) * 1992-10-13 1994-04-28 Baxter International Inc. Fluid sampling module
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
EP1396274B2 (en) * 2002-09-05 2013-05-22 Gambro Lundia AB Controller for a blood treatment equipment
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
JP4653218B2 (ja) * 2005-06-09 2011-03-16 ガンブロ・ルンディア・エービー 医療機器および医療機器をセットアップするための方法
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8888470B2 (en) 2007-02-27 2014-11-18 Deka Products Limited Partnership Pumping cassette
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
WO2010045558A1 (en) * 2008-10-17 2010-04-22 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
AU2011239489A1 (en) 2012-11-08
CA2796496A1 (en) 2011-10-20
EP2558967B1 (en) 2020-04-15
CO6630153A2 (es) 2013-03-01
MX389975B (es) 2025-03-20
JP6543279B2 (ja) 2019-07-10
EP2558967A1 (en) 2013-02-20
MX347513B (es) 2017-04-28
EP2558966A1 (en) 2013-02-20
NZ602996A (en) 2015-02-27
AU2011239488A1 (en) 2012-11-08
JP2013524892A (ja) 2013-06-20
JP2022095842A (ja) 2022-06-28
WO2011130668A1 (en) 2011-10-20
ES2802609T3 (es) 2021-01-20
JP2015221383A (ja) 2015-12-10
EP3706134A1 (en) 2020-09-09
JP6078582B2 (ja) 2017-02-08
WO2011130669A1 (en) 2011-10-20
JP2024045513A (ja) 2024-04-02
CA2796505A1 (en) 2011-10-20
JP6018567B2 (ja) 2016-11-02
JP7438257B2 (ja) 2024-02-26
MX2012012062A (es) 2013-06-28
BR112012026361A2 (pt) 2019-09-24
CA2796505C (en) 2018-12-11
JP7057321B2 (ja) 2022-04-19
ES2501715T3 (es) 2014-10-02
JP2015165914A (ja) 2015-09-24
CO6660434A2 (es) 2013-04-30
AU2011239488B2 (en) 2015-05-21
MX2022001536A (es) 2022-05-26
CA2796496C (en) 2018-03-20
EP2558966B1 (en) 2014-07-16
AU2011239489B2 (en) 2015-04-02
JP2017094150A (ja) 2017-06-01
JP6043850B2 (ja) 2016-12-14
JP2013524893A (ja) 2013-06-20
MX2012012061A (es) 2013-06-28
JP5747072B2 (ja) 2015-07-08
CO6620023A2 (es) 2013-02-15
JP2019188179A (ja) 2019-10-31

Similar Documents

Publication Publication Date Title
NZ603010A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
MX2016002083A (es) Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
WO2011092285A3 (en) Means and methods for diagnosing heart failure in a subject
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
EP4316567A3 (en) Counterpulsation device driver apparatus, method and system
MX2021010672A (es) Uso de un anticuerpo que tiene la capacidad para ligarse a clnd6 en el tratamiento o prevención de cáncer.
MX2010008720A (es) Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.
ZA201803207B (en) MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
MX2014011186A (es) Metodo para mejorar la eficiencia de las transfusiones de sangre.
WO2012018538A3 (en) Bioassays for determining pd-1 modulation
WO2010127136A3 (en) Measurement of body fluid volumes
WO2014026013A3 (en) Methods for maintaining or improving health, well-being and/or a physiological function in a subject
HK1209041A1 (en) A method of weight reduction
EP3153861A3 (en) Biomarkers for predicting response to a cancer vaccine
WO2019100086A3 (en) System for optimal hydration
WO2019053116A8 (en) Method for guidance of fluid therapy based on proadrenomedullin
WO2013049362A8 (en) Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis
UA58297U (ru) Способ оценки функционального состояния сердечно-сосудистой системы у детей школьного возраста
UA65525U (ru) Способ лечения больных ишемической болезнью сердца
RU2007100519A (ru) Способ лечения косоглазия у детей
Lelyavina et al. Efficiency of 9-component heart failure rehabilitation program on exercise capacity and 3-year survival of heart failure patients
UA40165U (ru) Способ оценки уровня кортизола у больных с ишемической болезнью сердца
UA69624U (uk) Спосіб профілактики загострення хронічного бронхіту у хворих зі сполученим перебігом з пептичною виразкою дванадцятипалої кишки
UA39014U (ru) Способ антикоагулянтной терапии во время проведения гемодиализа у больных с несостоятельной острой почечной дисфункцией
UA49567U (ru) Способ лечения хронических заболеваний кишечника у больных гипертонической болезнью

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE AGENT HAS BEEN CORRECTED TO 1078788, K+L GATES, K+L GATES BOX #1955, 24B MOOREFIELD ROAD, JOHNSONVILLE , WELLINGTON 6037, NZ; THE CONTACT HAS BEEN CORRECTED TO 1078788, K+L GATES, K+L GATES BOX #1955, 24B MOOREFIELD ROAD, JOHNSONVILLE , WELLINGTON 6037, NZ

Effective date: 20130422

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 15 APR 2016 BY COMPUTER PACKAGES INC

Effective date: 20150318

LAPS Patent lapsed